TOFACITINIB
NDC 72205-121, TOFACITINIB, solution, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-121
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217298
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE1 mg/mL
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-121-81 | 72205012181 | 240 mL in 1 BOTTLE (72205-121-81) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/327f6b60-1a5d-49e6-acff-18603d0ee9d0
Use it
Look up 72205-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.